Kirk CJ[au] - Search Results

Year	Number of Results
1954	1
1972	2
1973	1
1974	1
1975	2
1976	4
1977	1
1978	4
1979	4
1980	1
1981	5
1982	2
1983	3
1984	9
1985	4
1986	5
1987	8
1988	4
1989	4
1990	2
1991	4
1992	4
1993	5
1994	8
1995	9
1996	3
1997	2
1998	1
1999	4
2000	6
2001	5
2002	1
2003	2
2004	3
2005	4
2006	3
2007	2
2008	5
2009	3
2010	6
2011	7
2012	12
2013	5
2014	6
2015	2
2016	2
2017	1
2018	3
2019	2
2021	3
2022	2
2023	5
2024	2

1

Proteasome composition in immune cells implies special immune‐cell‐specific immunoproteasome function.

Inholz K, Anderl JL, Klawitter M, Goebel H, Maurits E, Kirk CJ, Fan RA, Basler M. Inholz K, et al. Among authors: kirk cj. Eur J Immunol. 2024 Apr;54(4):e2350613. doi: 10.1002/eji.202350613. Epub 2024 Mar 8. Eur J Immunol. 2024. PMID: 38458995 Italian.

2

Signal peptide mimicry primes Sec61 for client-selective inhibition.

Rehan S, Tranter D, Sharp PP, Craven GB, Lowe E, Anderl JL, Muchamuel T, Abrishami V, Kuivanen S, Wenzell NA, Jennings A, Kalyanaraman C, Strandin T, Javanainen M, Vapalahti O, Jacobson MP, McMinn D, Kirk CJ, Huiskonen JT, Taunton J, Paavilainen VO. Rehan S, et al. Among authors: kirk cj. Nat Chem Biol. 2023 Sep;19(9):1054-1062. doi: 10.1038/s41589-023-01326-1. Epub 2023 May 11. Nat Chem Biol. 2023. PMID: 37169961 Free PMC article.

3

Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism.

Wang J, Fang Y, Fan RA, Kirk CJ. Wang J, et al. Among authors: kirk cj. Int J Mol Sci. 2021 Oct 27;22(21):11595. doi: 10.3390/ijms222111595. Int J Mol Sci. 2021. PMID: 34769030 Free PMC article. Review.

4

Discovery and Early Clinical Development of Selective Immunoproteasome Inhibitors.

Kirk CJ, Muchamuel T, Wang J, Fan RA. Kirk CJ, et al. Cells. 2021 Dec 21;11(1):9. doi: 10.3390/cells11010009. Cells. 2021. PMID: 35011570 Free PMC article. Review.

5

The immunoproteasome in antigen processing and other immunological functions.

Basler M, Kirk CJ, Groettrup M. Basler M, et al. Among authors: kirk cj. Curr Opin Immunol. 2013 Feb;25(1):74-80. doi: 10.1016/j.coi.2012.11.004. Epub 2012 Dec 6. Curr Opin Immunol. 2013. PMID: 23219269 Review.

6

Discovery and development of second-generation proteasome inhibitors.

Kirk CJ. Kirk CJ. Semin Hematol. 2012 Jul;49(3):207-14. doi: 10.1053/j.seminhematol.2012.04.007. Semin Hematol. 2012. PMID: 22726543 Review.

7

Proteasomes in immune cells: more than peptide producers?

Groettrup M, Kirk CJ, Basler M. Groettrup M, et al. Among authors: kirk cj. Nat Rev Immunol. 2010 Jan;10(1):73-8. doi: 10.1038/nri2687. Epub 2009 Dec 11. Nat Rev Immunol. 2010. PMID: 20010787 Review.

8

Diagnostic accuracy of intraoral photographic orthodontic records.

Jackson TH, Kirk CJ, Phillips C, Koroluk LD. Jackson TH, et al. Among authors: kirk cj. J Esthet Restor Dent. 2019 Jan;31(1):64-71. doi: 10.1111/jerd.12426. Epub 2018 Oct 31. J Esthet Restor Dent. 2019. PMID: 30381885 Clinical Trial.

9

Development of proteasome inhibitors in oncology and autoimmune diseases.

Bennett MK, Kirk CJ. Bennett MK, et al. Among authors: kirk cj. Curr Opin Drug Discov Devel. 2008 Sep;11(5):616-25. Curr Opin Drug Discov Devel. 2008. PMID: 18729013 Review.

10

Phytoestrogens and xenoestrogens: the contribution of diet and environment to endocrine disruption.

Waring RH, Ayers S, Gescher AJ, Glatt HR, Meinl W, Jarratt P, Kirk CJ, Pettitt T, Rea D, Harris RM. Waring RH, et al. Among authors: kirk cj. J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):213-20. doi: 10.1016/j.jsbmb.2007.09.007. Epub 2007 Sep 7. J Steroid Biochem Mol Biol. 2008. PMID: 17933522 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

188 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year